From January 1, 2024 to March 31, 2024, the company has repurchased 1,616,155 shares, representing 1.78% for CNY 70.43 million. With this, the company has completed the repurchase of 1,616,155 shares, representing 1.78% for CNY 70.43 million under the buyback announced on December 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.72 CNY | +0.68% | -4.88% | -41.05% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.05% | 410M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+43.91% | 40.47B | |
-10.87% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- 688073 Stock
- News Bide Pharmatech Co., Ltd.
- Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.